HopeStage
Back to all studies
CompletedNCT00475137

Lamotrigine alone or with an antidepressant for bipolarity type II depression

About this titleRead the official source — NCT00475137
Medication studyAges 17–70Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with type II bipolarity. Listed age limits: 17 years to 70 years. Other eligibility criteria applied.

Listed locations
VancouverSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2007
Recruitment status
Completed
Enrollment listed in the registry
15
Sponsor
University of British Columbia
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 17 Years to 70 Years
Official registry ID
NCT00475137
Official title
Show the full official title

A Randomized, Single-Blind Comparison of Lamotrigine Add-on Versus Switch to Lamotrigine Monotherapy in the Treatment of Bipolar II Depression Unresponsive to Antidepressant Treatment

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Vancouver

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of British Columbia, a university.

Did this study involve medication?

Yes. The study involved medication, including lamotrigine.

Who was this study for?

This study was for people with type II bipolarity. Listed age limits: 17 years to 70 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies